Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
PVX-410 + Pembrolizumab for Advanced Breast Cancer
Recruiting2 awardsPhase 1
Boston, Massachusetts
This trial is studying whether a combination of PVX-410, pembrolizumab, Hiltonol, and Montanide can help to treat triple-negative breast cancer that has spread to other parts of the body and cannot be removed by surgery.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.